Accessibility Menu
ClearPoint Neuro logo

ClearPoint Neuro

(NASDAQ) CLPT

Current Price$13.82
Market Cap$412.36M
Since IPO (2012)-54%
5 Year-30%
1 Year+3%
1 Month+12%

ClearPoint Neuro Financials at a Glance

Market Cap

$412.36M

Revenue (TTM)

$40.61M

Net Income (TTM)

-$29.07M

EPS (TTM)

-$1.01

P/E Ratio

-13.64

Dividend

$0.00

Beta (Volatility)

1.90 (High)

Price

$13.82

Volume

17,242

Open

$14.10

Previous Close

$13.82

Daily Range

$13.43 - $14.10

52-Week Range

$8.27 - $30.10

Estimated Earnings Date

Aug 11, 2026

CLPT News

No articles available.

CLPT: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ClearPoint Neuro

Industry

Healthcare Equipment and Supplies

Employees

172

CEO

Joseph Michael Burnett, MBA

Headquarters

Solana Beach, CA 92075, US

CLPT Financials

Key Financial Metrics (TTM)

Gross Margin

62%

Operating Margin

-65%

Net Income Margin

-72%

Return on Equity

-150%

Return on Capital

-32%

Return on Assets

-31%

Earnings Yield

-7.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$412.36M

Shares Outstanding

29.99M

Volume

17.24K

Avg. Volume

590.75K

Financials (TTM)

Gross Profit

$22.69M

Operating Income

-$24.16M

EBITDA

-$21.93M

Operating Cash Flow

-$23.93M

Capital Expenditure

-$522.00K

Free Cash Flow

-$24.45M

Cash & ST Invst.

$45.92M

Total Debt

$58.23M

ClearPoint Neuro Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$12.13M

+42.9%

Gross Profit

$7.55M

+47.1%

Gross Margin

62.24%

N/A

Market Cap

$412.36M

N/A

Market Cap/Employee

$3.59M

N/A

Employees

115

N/A

Net Income

-$9.55M

-58.5%

EBITDA

-$7.37M

-26.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$35.59M

+187.3%

Total Debt

$63.59M

+1749.6%

Accounts Receivable

$8.66M

+137.3%

Inventory

$8.57M

+30.2%

Long Term Debt

$63.35M

+2115.2%

Short Term Debt

$234.00K

-59.5%

Return on Assets

-31.11%

N/A

Return on Invested Capital

-31.55%

N/A

Free Cash Flow

-$8.61M

-35.5%

Operating Cash Flow

-$7.97M

-29.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNDLSNDL Inc.
$1.46+0.69%
OFIXOrthofix Medical Inc.
$9.23-5.14%
VREXVarex Imaging Corporation
$11.03+4.75%
LABStandard BioTools Inc.
$0.91+2.93%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.65+0.09%
SPCEVirgin Galactic
$5.73+0.22%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.83-0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.04-0.05%

Questions About CLPT

What is the current price of ClearPoint Neuro?

ClearPoint Neuro is trading at $13.82 per share.

What is the 52-week range for ClearPoint Neuro?

Over the past 52 weeks, ClearPoint Neuro has traded between $8.27 and $30.10.

How much debt does ClearPoint Neuro have?

As of the most recent reporting period, ClearPoint Neuro reported total debt of $63.59M.

How much cash does ClearPoint Neuro have on hand?

ClearPoint Neuro reported $35.59M in cash and cash equivalents in its most recent financial results.

What is ClearPoint Neuro’s dividend yield?

ClearPoint Neuro does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.